Quark Pharma Raises $10 Million
Quark Pharmaceuticals Inc., a Fremont, Calif.-based developer of RNA interference-based therapeutics, has raised $10 million in new VC funding from existing backer SBI Holdings Group (Japan).
10 June 2010•3 mins read
Quark Pharmaceuticals Inc., a Fremont, Calif.-based developer of RNA interference-based therapeutics, has raised $10 million in new VC funding from existing backer SBI Holdings Group (Japan).
